- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Not active orphans
- (3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid
Pharmaceuticals - Community Register
Community list of not active orphan medicinal products |
WITHDRAWN |
Product information |
(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid
EU orphan designation number: | EU/3/05/277 |
Active ingredient: | (3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid |
Indication: | Treatment of cystic fibrosis |
Sponsor: | PTC Therapeutics International Limited
77 Sir John Rogerson’s Quay, Dublin 2, Ireland |
Public summary of scientific opinion
European Commission procedures |